Prenatal development

Global Down Syndrome Foundation Launches Matching “21 for 21” Campaign for World Down Syndrome Day with Support from the Safeway Foundation

Retrieved on: 
Thursday, March 14, 2024

World Down Syndrome Day was promulgated by the United Nations in 2012 and is celebrated in 190 countries.

Key Points: 
  • World Down Syndrome Day was promulgated by the United Nations in 2012 and is celebrated in 190 countries.
  • To learn more about the Global Down Syndrome Foundation and World Down Syndrome Day, visit www.globaldownsyndrome.org/world-down-syndrome-day-month .
  • The Global Down Syndrome Foundation (GLOBAL) is the largest non-profit in the U.S. working to save lives and dramatically improve health outcomes for people with Down syndrome.
  • GLOBAL’s widely circulated medical publications include GLOBAL Medical Care Guidelines for Adults with Down Syndrome , Prenatal & Newborn Down Syndrome Information , and the award-winning Down Syndrome World™ magazine.

Evidence review: Maternal mental conditions drive climbing death rate in U.S.

Retrieved on: 
Wednesday, February 21, 2024

“The contribution of mental health conditions to the maternal morbidity and mortality crisis that we have in America is not widely recognized,” said Katherine L. Wisner, M.D.

Key Points: 
  • “The contribution of mental health conditions to the maternal morbidity and mortality crisis that we have in America is not widely recognized,” said Katherine L. Wisner, M.D.
  • , associate chief of Perinatal Mental Health and member of the Center for Prenatal, Neonatal & Maternal Health Research at Children’s National.
  • Overdose and other maternal mental health conditions are taking the lives of more than twice as many women as postpartum hemorrhage, the second leading cause of maternal death.
  • Mental health conditions such as suicide or opioid overdose are to blame for nearly 23% of maternal deaths in America, according to reports from three dozen Maternal Morbidity and Mortality Review Committees, which are state-based organizations that review each maternal death within a year of pregnancy.

In-Vitro Diagnostics Business Updates Service - ResearchAndMarkets.com

Retrieved on: 
Thursday, February 8, 2024

Figure: Agilent Sales, by Business (Agilent Crosslab Group, Diagnostics and Genomics Group, Life Sciences and Applied Markets Group), Fy 2022 and Fy 2023

Key Points: 
  • Figure: Agilent Sales, by Business (Agilent Crosslab Group, Diagnostics and Genomics Group, Life Sciences and Applied Markets Group), Fy 2022 and Fy 2023
    Figure: Agilent Sales, by Business (Agilent Crosslab Group, Diagnostics and Genomics Group, Life Sciences and Applied Markets Group), Fy 2023 Quarterly Performance
    Figure: Agilent Fy 2023 Regional Sales Breakdown Distribution, by Region (Americas, Asia-Pacific, Europe) (%)
    Table: Hologic Diagnostic Sales Performance, by Product Group (Blood Screening, Cytology & Perinatal, Molecular Diagnostics), Fy 2023 ($ Millions)
    Figure: Hologic Revenue, by Product Group (Blood Screening, Cytology & Perinatal, Molecular Diagnostics), Fy 2022 and Fy 2023 ($ Millions)

Annals of Family Medicine: The risk of death during or shortly after childbirth is higher for people in the US than in other developed countries.

Retrieved on: 
Thursday, January 25, 2024

PROVIDENCE, R.I., Jan. 25, 2024 /PRNewswire/ -- In a new article published in Annals of Family Medicine, "A Mixed Methods Evaluation of a Quality Improvement Model to Optimize Perinatal and Primary Care in the Community Health Setting," researchers assessed a quality improvement learning collaborative's (QILC) intervention to link high-risk prenatal patients with primary care. The aims of the study were twofold: to measure the impact of the intervention on postpartum and primary care utilization for high-risk prenatal patients and to explore the Federally Qualified Health Center (FQHC) participants' experiences of working with a QI collaborative.

Key Points: 
  • Using information from patient's health records, 19 clinics within the six participating FQHCs identified high-risk prenatal patients who delivered between January and June 2021.
  • The QI intervention implemented a patient registry and conducted direct patient outreach for six months after delivery to connect patients to primary care.
  • At the conclusion of the intervention, all six FQHCs had successfully implemented processes for coordinating their maternal and primary care.
  • Complete editorial content and interactive discussion groups for each published article can be accessed for free on the journal's website, www.AnnFamMed.org .

Point-of-Care Molecular Diagnostics Market Expected to Reach USD 10.12 Billion by 2030, Driven by Technological Advancements and Growing Geriatric Population - ResearchAndMarkets.com

Retrieved on: 
Tuesday, January 9, 2024

Recent findings suggest an impending upsurge in the global Point-of-Care (POC) Molecular Diagnostics market, with forecasts estimating a valuation of USD 10.12 billion by the year 2030.

Key Points: 
  • Recent findings suggest an impending upsurge in the global Point-of-Care (POC) Molecular Diagnostics market, with forecasts estimating a valuation of USD 10.12 billion by the year 2030.
  • This relates to a Compound Annual Growth Rate (CAGR) of 2.5% over the period from 2024 to 2030.
  • The market analysis indicates a substantial need for POC molecular diagnostics, particularly for infections like COVID-19 and HIV, and to bolster ongoing monitoring in home healthcare settings.
  • The research addresses crucial data that underpin strategic decisions and forecasted growth, setting the stage for ongoing and future developments in the POC molecular diagnostics landscape.

Enable Biosciences Inc. Reveals Key Findings on COVID-19 Transmission from Mothers to Newborns

Retrieved on: 
Wednesday, January 3, 2024

This research is crucial in understanding how maternal antibodies against SARS-CoV-2 are transferred to and persist in newborns.

Key Points: 
  • This research is crucial in understanding how maternal antibodies against SARS-CoV-2 are transferred to and persist in newborns.
  • The study involved analyzing dried blood spots from newborns for the presence of these antibodies.
  • With 15.7% of newborns testing positive, the study provides new insights into the prevalence and longevity of maternal antibodies, highlighting a significant maternal transmission rate.
  • Dr. Jason Tsai, CTO of Enable Biosciences, commented, "This study is a landmark in neonatal research, offering unprecedented insights into maternal-to-neonatal antibody transfer.

Orion Research Foundation grants EUR 1,112,000 for research in 2024

Retrieved on: 
Wednesday, November 15, 2023

Orion Research Foundation sr is distributing EUR 1,112,000 in research grants based on applications for 2024.

Key Points: 
  • Orion Research Foundation sr is distributing EUR 1,112,000 in research grants based on applications for 2024.
  • Orion Reaserch Foundation awards grants of max EUR 50,000 for 17 researchers for postdoctoral research and max EUR 6,000 for 95 young researchers for doctoral dissertation work.
  • One of the postdoctoral grants was distributed from Maritza and Reino Salonen’s Fund which is administered by Orion Research Foundation.
  • Orion Research Foundation sr is annually distributing its return on investment and donations from Orion Corporation as grants for young researchers for doctoral dissertation work and postdoctoral research.

Hemet Global Medical Center Voted “Best Hospital” in the Inland Empire by Press-Enterprise Readers for 2023

Retrieved on: 
Tuesday, October 17, 2023

ORANGE, Calif., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Hemet Global Medical Center (“HGMC”), a KPC Health hospital, has been voted “Best Hospital” in the Inland Empire for 2023 by Press-Enterprise readers.

Key Points: 
  • ORANGE, Calif., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Hemet Global Medical Center (“HGMC”), a KPC Health hospital, has been voted “Best Hospital” in the Inland Empire for 2023 by Press-Enterprise readers.
  • The distinguished honor is part of the Press-Enterprise’s 28th Annual “Best of Inland Empire” Readers’ Choice awards for local businesses.
  • “Prior to KPC Health’s acquisition of Hemet Global Medical Center, this was a hospital on the brink of bankruptcy that many believed could not be saved,” said Dr. Kali P. Chaudhuri, Founder and Chairman of the KPC Group.
  • KPC Health’s current system of hospitals includes seven full-service acute care hospitals located throughout southern California, including Orange County Global Medical Center, Chapman Global Medical Center, Anaheim Global Medical Center, South Coast Global Medical Center, Hemet Global Medical Center, Menifee Global Medical Center, and Victor Valley Global Medical Center.

UPDATE | Advanced imaging reveals altered brain chemistry of babies with congenital heart disease

Retrieved on: 
Monday, October 9, 2023

They found:

Key Points: 
  • They found:
    Those with CHD had higher levels of choline and lower levels of N-Acetyl aspartate-to-choline ratios compared to healthy babies, potentially representing disrupted brain development.
  • Babies with more complex CHD also had higher levels of cerebral lactate compared to babies with two ventricle CHD.
  • These critical heart defects generally require babies to undergo heart surgery not long after birth.
  • , chief of the Advanced Technologies and Surgery Branch in the Division of Cardiovascular Sciences at the National Heart, Lung and Blood Institute.

Advanced imaging reveals altered brain chemistry of babies with congenital heart disease

Retrieved on: 
Monday, October 9, 2023

They found:

Key Points: 
  • They found:
    Those with CHD had higher levels of choline and lower levels of N-Acetyl aspartate-to-choline ratios compared to healthy babies, potentially representing disrupted brain development.
  • Babies with more complex CHD also had higher levels of cerebral lactate compared to babies with two ventricle CHD.
  • These critical heart defects generally require babies to undergo heart surgery not long after birth.
  • , chief of the Advanced Technologies and Surgery Branch in the Division of Cardiovascular Sciences at the National Heart, Lung and Blood Institute.